Portal venous stent placement in patients with pancreatic and biliary neoplasms invading portal veins and causing portal hypertension: initial experience

• Published in: Radiology Vol. 220; no. 1; p. 150
• Main Authors: Yamakado, K, Nakatsuka, A, Tanaka, N, Fujii, A, Isaji, S, Kawarada, Y, Takeda, K
• Format: Journal Article
• Language: English
• Published: United States 01.07.2001
• Subjects: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms - complications; Bile Duct Neoplasms - diagnosis; Cholestasis, Extrahepatic - complications; Cholestasis, Extrahepatic - diagnosis; Female; Follow-Up Studies; Humans; Hypertension, Portal - etiology; Hypertension, Portal - therapy; Male; Middle Aged; Neoplasm Invasiveness; Pancreatic Neoplasms - complications; Pancreatic Neoplasms - diagnosis; Portal Vein - diagnostic imaging; Portal Vein - pathology; Portography; Probability; Stents; Treatment Outcome; Vascular Patency
• ISSN: 0033-8419
• DOI: 10.1148/radiology.220.1.r01jl03150

To evaluate the clinical usefulness of portal venous stent placement in patients with pancreatic or biliary neoplasms invading portal veins and causing portal hypertension. Thirteen patients underwent portal venous stent placement because of gastrointestinal bleeding (n = 8), risk of gastroesophageal varix rupture (n = 4), ascites (n = 4), thrombocytopenia (n = 3), and/or portal venous thrombosis (n = 3). The main portal vein or both the intrahepatic and main portal veins were invaded in six patients (group A). The main portal vein and splanchnic veins were involved in seven patients (group B). Stents were placed across the stenotic (n = 8) or occluded (n = 5) lesions after percutaneous transhepatic portography. Changes in portal venous pressure, stent patency, and survival were evaluated. Mean portal venous pressure decreased significantly immediately after stent placement, from 24.9 mm Hg +/- 5.9 (SD) to 15.8 mm Hg +/- 4.6 (P <.001). In group A, blood flow through the stent was maintained and the symptoms had subsided at follow-up (mean, 12.5 months). In group B, symptoms were improved in five patients, but the stents were occluded in all but one patient at a mean follow-up of 1.5 months. There was a significant difference in stent patency between the patients with (14%) and those without (100%) splanchnic venous involvement (P <.01). Stent placement helped to relieve portal hypertension symptoms. Splanchnic venous involvement was associated with worse stent patency.